esterbut-3 has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Magnien, V; Planchon, P; Prevost, G; Starzec, A | 1 |
| Brouty-Boyé, D; Crépin, M; Magnien, V; Planchon, P; Raux, H; Ronco, G; Villa, P | 1 |
2 other study(ies) available for esterbut-3 and Breast Cancer
| Article | Year |
|---|---|
Selection of a highly tumorigenic breast cancer cell line sensitive to estradiol to evidence in vivo the tumor-inhibitory effect of butyrate derivative Monobut-3.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Butyrates; Carcinoma, Ductal, Breast; Cell Division; Estradiol; Female; Glucose; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Tumor Cells, Cultured | 1994 |
New stable butyrate derivatives alter proliferation and differentiation in human mammary cells.
Topics: Antigens, Surface; Breast Neoplasms; Butyrates; Cell Cycle; Cell Differentiation; Cell Division; Cell Line; Dose-Response Relationship, Drug; Female; Flow Cytometry; Glucose; Humans; Receptors, Estrogen | 1991 |